Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI ...

KUWAIT: In a pioneering medical achievement, Dr Ahmed Amir, Consultant Vascular Surgeon at Jaber Al-Ahmad Hospital, has successfully performed the first arterial bypass operation in Kuwait and the ...

The FIB-4 score, a noninvasive marker used to assess liver fibrosis based on age, liver enzyme levels, and platelet count, ...

Stem cell therapies are gradually becoming a viable medical option for a range of health conditions. Today, a micro-cap ...

Hemostemix Inc. Begins Commercial Offering of ACP-01 (VesCell) for Ischemic Pain Treatments in Florida. Calgary, ...

From 1970 to 2022, there was a decrease in heart disease mortality overall, but an increase in mortality from other heart ...

By establishing an iron overload-induced hepatic ferroptosis model, scientists from Japan have identified iFerroptosis—an ...

In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, highlights first-time ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...